Alzheimer's disease (AD) is a chronic neurodegenerative disease in the central nervous
system that has complex pathogenesis in the elderly. The current review focuses on the …

Abstract DNA methylation (5-methylcytosine [5mC]) is one of several epigenetic markers
altered in Alzheimer's disease (AD) brain. More recently, attention has been given to DNA …

Research over the years has shown that causes of Alzheimer's disease are not well
understood, but over the past years, the involvement of epigenetic mechanisms in the …

Epigenetics (particularly DNA methylation) together with environmental and genetic factors,
are key to understanding the pathogenesis of many diseases including dementia …

Aims Genetic factors do not seem to account fully for A lzheimer disease (AD) pathogenesis.
There is evidence for the contribution of environmental factors, whose effect may be …

Alzheimer's disease (AD) is a common, progressive neurodegenerative disorder without
highly effective therapies. The etiology of AD is heterogeneous with amyloid-beta plaques …

Epigenetic alterations have been associated with several human diseases including
Alzheimer's disease (AD). AD is a complex neurodegenerative disease characterized by a …

High homocysteine (Hcy) together with low S-adenosylmethionine (SAM) levels are often
observed in Alzheimer disease (AD), and this could be a sign of alteration of SAM/Hcy …

The sporadic form of Alzheimer disease, late onset Alzheimer's disease (LOAD), is a
multifactorial disease; a strong link between nutritional and genetic factors with normal aging …

The gene based therapeutics and drug targets have shown incredible and appreciable
advances in alleviating human sufferings and complexities. Epigenetics simply means …